miR-493 Promotes Prostate Cancer Cells Proliferation by Targeting PHLPP2 and Activating Akt Signaling Pathway

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• MicroRNA-493 (miR-493) is upregulated in prostate cancer (PCa).
• The precise mechanism of miR-493's pro-proliferative role in PCa remains to be fully elucidated.
• Understanding miR-493's function is crucial for developing targeted PCa therapies.

Purpose of the Study:

• To investigate the mechanism by which miR-493 promotes proliferation in PCa cells.
• To determine the role of PH domain leucine-rich-repeats protein phosphatase 2 (PHLPP2) and the Akt signaling pathway in miR-493's function.
• To explore miR-493 as a potential therapeutic target in PCa.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to measure miR-493 expression in PCa cell lines (DU145, PC3) and control cells.
• Transfection of PCa cells with miR-493 mimics, inhibitors, PHLPP2, and Akt expressing plasmids, alongside treatment with Akt inhibitor MK-2206.
• Assessment of cell proliferation, miRNA/mRNA expression, and protein levels via western blotting.

Main Results:

• miR-493 expression was significantly higher in PCa cells compared to normal RWPE-1 cells.
• Overexpression of miR-493 led to increased cell proliferation and decreased PHLPP2 expression, while PHLPP2 overexpression inhibited proliferation.
• Inhibition of the Akt pathway with MK-2206 attenuated miR-493-driven proliferation, suggesting Akt activation is critical.

Conclusions:

• miR-493 functions as an onco-microRNA in prostate cancer.
• miR-493 promotes PCa cell proliferation by suppressing PHLPP2 and activating the Akt signaling pathway.
• Targeting miR-493 or the PHLPP2/Akt axis may offer a novel therapeutic strategy for PCa.